Shennan Circuit (002916 CH)
3Q26 earnings: Continued margin expansion fueled by AI demand
SCC delivered strong 3Q26 results, with revenue/net profit rising 66.3%/94.4% YoY and 20.4%/34.0% QoQ to RMB10.48bn/RMB1.88bn. Net profit was near the upper end of the profit alert range, while NPM expanded to 17.9%, from 16.1% in 2Q26 and 15.3% in 3Q25. GPM also improved to 34.9%, vs. 32.4%/31.4% in 2Q26/3Q25, driven by robust AI infrastructure demand, a richer product mix, high capacity utilization and the continued ramp-up of the Guangzhou plant. We adjust up the revenue estimates by 9.3%/9.8% and GPM estimates by 0.5ppt/0.3ppt in FY26/27E on surging demand and more favorable product mix. Maintain BUY but lower our TP to RMB432 from RMB462, as we reduce our target multiple to 31x 2027E P/E from 37x, broadly in line with the peer average.
AI demand and product upgrades drove broad-based growth. According to mgmt., continued investment in AI infrastructure supported demand for AI servers, high-speed switches, optical modules, processors and memory-related substrates. High capacity utilization, product-mix improvement and the Guangzhou plant ramp-up altogether drove earnings growth. In 9M26, revenue/net profit increased 53.8%/77.5% YoY to RMB25.77bn/RMB4.13bn, while GPM expanded 4.4ppt to 32.6%. Net profit grew 87.8% despite higher finance expenses and lower government-related income, indicating solid underlying profitability.
AI-related products and new capacity to drive the growth outlook. We expect AI-related PCBs, BT substrates, FC-BGA and ABF products to remain the key growth drivers into 2027E, supported by capacity expansion in Guangzhou, Thailand, Nantong and Wuxi. Further margin upside will depend on product-mix improvement and utilization gains to more than offset raw material inflation, ramp-up costs and incremental depreciation.
<sup></sup> Key risks include weaker hyperscalers’ capex, slower client qualification, slower capacity ramp-up, etc.
Earnings Summary
| (YE 31 Dec) | FY24A | FY25A | FY26E | FY27E | FY28E |
| Revenue (RMB mn) | 17,907 | 23,647 | 36,783 | 47,828 | 61,823 |
| YoY growth (%) | 32.4 | 32.1 | 55.6 | 30.0 | 29.3 |
| Gross margin (%) | 24.8 | 28.3 | 32.4 | 33.9 | 35.8 |
| Net profit (RMB mn) | 1,877.6 | 3,275.7 | 6,115.3 | 9,295.5 | 13,255.3 |
| YoY growth (%) | 34.3 | 74.5 | 86.7 | 52.0 | 42.6 |
| EPS (Reported) (RMB) | 3.66 | 4.91 | 9.17 | 13.94 | 19.88 |
| P/E (x) | 77.7 | 57.9 | 31.0 | 20.4 | 14.3 |
| ROE (%) | 13.5 | 20.6 | 31.4 | 36.4 | 38.4 |
Source: Company data, Bloomberg, CMBIGM estimates
BUY (Maintain)
Target Price RMB432.00
(Previous TP RMB462.00)
Up/Downside 52.0%
Current Price RMB284.30
China Semiconductors
Zhimin ZHOU (852) 3850 5268 zhouzhimin@cmbi.com.hk
Kevin ZHANG (852) 3761 8727 kevinzhang@cmbi.com.hk
Aaron GUO (852) 3916 3715 aaronguo@cmbi.com.hk
Stock Data
| Mkt Cap (RMB mn) | 189,059.5 |
| Avg 3 mths t/o (RMB mn) | 3,214.1 |
| 52w High/Low (RMB) | 457.90/187.41 |
| Total Issued Shares (mn) | 665.0 |
| Source: FactSet | |
Shareholding Structure
| Shentian Tech | 62.6% |
| E Fund Management | 2.7% |
| Source: Bloomberg | |
Share Performance
| Absolute | Relative | |
| 1-mth | -28.9% | -16.5% |
| 3-mth | -15.9% | -4.2% |
| 6-mth | -5.6% | 21.8% |
Source: FactSet
Figure 1: Earnings forecasts update
| RMB mn | New | Old | Diff. (%) | ||||||
| FY26E | FY27E | FY28E | FY26E | FY27E | FY28E | FY26E | FY27E | FY28E | |
| Revenue | 36,783 | 47,828 | 61,823 | 33,644 | 43,550 | 56,105 | 9.3% | 9.8% | 10.2% |
| Gross profit | 11,917 | 16,193 | 22,135 | 10,716 | 14,639 | 19,932 | 11.2% | 10.6% | 11.1% |
| Net profit | 6,115 | 9,295 | 13,255 | 5,470 | 8,326 | 11,932 | 11.8% | 11.6% | 11.1% |
| EPS (RMB) | 9.17 | 13.94 | 19.88 | 8.20 | 12.49 | 17.90 | 11.9% | 11.6% | 11.1% |
| Gross margin | 32.4% | 33.9% | 35.8% | 31.9% | 33.6% | 35.5% | 0.5 ppt | 0.3 ppt | 0.3 ppt |
| Net margin | 16.6% | 19.4% | 21.4% | 16.3% | 19.1% | 21.3% | 0.3 ppt | 0.3 ppt | 0.1 ppt |
Source: Company data, CMBIGM estimates
Figure 2: CMBIGM forecast vs. Bloomberg consensus
| CMBIGM estimates | Bloomberg consensus | Diff (%) | |||||||
| RMB mn | FY26E | FY27E | FY28E | FY26E | FY27E | FY28E | FY26E | FY27E | FY28E |
| Revenue | 36,783 | 47,828 | 61,823 | 33,834 | 45,846 | 59,011 | 8.7% | 4.3% | 4.8% |
| Gross profit | 11,917 | 16,193 | 22,135 | 10,705 | 15,649 | 20,977 | 11.3% | 3.5% | 5.5% |
| Net profit | 6,115 | 9,295 | 13,255 | 5,783 | 9,036 | 12,400 | 5.7% | 2.9% | 6.9% |
| EPS (RMB) | 9.17 | 13.94 | 19.88 | 8.55 | 13.45 | 18.48 | 7.3% | 3.7% | 7.6% |
| Gross margin | 32.4% | 33.9% | 35.8% | 31.6% | 34.1% | 35.5% | 0.8 ppt | -0.3 ppt | 0.3 ppt |
| Net margin | 16.6% | 19.4% | 21.4% | 17.1% | 19.7% | 21.0% | -0.5 ppt | -0.3 ppt | 0.4 ppt |
Source: Company data, CMBIGM estimates, Bloomberg consensus
Figure 3: Peer table
| Company | Ticker | P/E (x) | EPS (US$) | GPM% | |||
| CY26E | CY27E | CY26E | CY27E | CY26E | CY27E | ||
| Shengyi Elec. | 688183 CH | 26.8 | 17.6 | 0.48 | 0.73 | 34.3 | 35.0 |
| Avary | 002938 CH | 31.4 | 20.6 | 0.33 | 0.51 | 24.2 | 25.9 |
| WUS | 002463 CH | 32.2 | 20.9 | 0.50 | 0.77 | 38.8 | 40.3 |
| Victory Giant | 300476 CH | 21.1 | 11.4 | 1.27 | 2.34 | 36.2 | 38.8 |
| Ibiden | 4062 JT | 89.3 | 54.2 | 0.62 | 1.00 | 31.9 | 38.0 |
| Fastprint | 002436 CH | 137.3 | 63.6 | 0.04 | 0.08 | 24.1 | 27.2 |
| Unimicron | 3037 TT | 49.0 | 26.0 | 0.68 | 1.29 | 26.1 | 36.6 |
| Average | 55.3 | 30.6 | 0.56 | 0.96 | 30.8 | 34.5 | |
Source: Company data, CMBIGM, Bloomberg consensus as of 22 Oct, 2026
Financial Summary
| INCOME STATEMENT | 2023A | 2024A | 2025A | 2026E | 2027E | 2028E |
| YE 31 Dec (RMB mn) | ||||||
| Revenue | 13,526 | 17,907 | 23,647 | 36,783 | 47,828 | 61,823 |
| Cost of goods sold | (10,357) | (13,460) | (16,951) | (24,866) | (31,635) | (39,687) |
| Gross profit | 3,170 | 4,447 | 6,696 | 11,917 | 16,193 | 22,135 |
| Operating expenses | (1,558) | (2,141) | (2,642) | (4,235) | (5,124) | (6,128) |
| SG&A expense | (870) | (1,030) | (1,446) | (2,248) | (2,780) | (3,408) |
| R&D expense | (1,073) | (1,272) | (1,591) | (2,207) | (2,631) | (3,091) |
| Others | 385 | 161 | 396 | 221 | 287 | 371 |
| Operating profit | 1,611 | 2,306 | 4,054 | 7,683 | 11,070 | 16,007 |
| Other income | 5 | 6 | 6 | 0 | 0 | 0 |
| Other expense | (4) | (11) | (18) | 0 | 0 | 0 |
| Other gains/(losses) | (182) | (231) | (370) | (449) | (199) | (621) |
| Interest income | 12 | 10 | 16 | 14 | 42 | 78 |
| Interest expense | (66) | (80) | (78) | (137) | (158) | (170) |
| Others | 23 | 23 | 13 | (237) | (308) | (398) |
| Pre-tax profit | 1,398 | 2,023 | 3,624 | 6,874 | 10,447 | 14,897 |
| Income tax | (1) | (145) | (345) | (756) | (1,149) | (1,639) |
| After tax profit | 1,398 | 1,879 | 3,279 | 6,118 | 9,298 | 13,258 |
| Minority interest | (0) | 1 | 3 | 3 | 3 | 3 |
| Net profit | 1,398 | 1,878 | 3,276 | 6,115 | 9,295 | 13,255 |
| BALANCE SHEET | 2023A | 2024A | 2025A | 2026E | 2027E | 2028E |
| YE 31 Dec (RMB mn) | ||||||
| Current assets | 8,597 | 10,854 | 13,654 | 21,986 | 28,378 | 40,914 |
| Cash & equivalents | 853 | 1,553 | 998 | 1,894 | 6,542 | 9,160 |
| Account receivables | 3,091 | 3,806 | 5,250 | 10,068 | 9,587 | 15,819 |
| Inventories | 2,686 | 3,395 | 5,140 | 6,442 | 8,292 | 10,192 |
| Prepayment | 8 | 9 | 36 | 26 | 40 | 48 |
| Other current assets | 1,959 | 2,091 | 2,230 | 3,555 | 3,917 | 5,695 |
| Non-current assets | 14,010 | 14,448 | 16,929 | 20,525 | 23,970 | 28,235 |
| PP&E | 10,083 | 12,396 | 13,339 | 15,009 | 17,198 | 19,871 |
| Right-of-use assets | 26 | 9 | 61 | 139 | 232 | 343 |
| Deferred income tax | 272 | 187 | 259 | 359 | 443 | 585 |
| Intangibles | 544 | 585 | 639 | 769 | 942 | 1,168 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-current assets | 3,085 | 1,271 | 2,631 | 4,248 | 5,155 | 6,269 |
| Total assets | 22,607 | 25,302 | 30,583 | 42,511 | 52,348 | 69,149 |
| Current liabilities | 6,425 | 7,489 | 10,024 | 17,056 | 19,179 | 25,100 |
| Short-term borrowings | 400 | 10 | 15 | 5,141 | 3,660 | 6,350 |
| Account payables | 2,037 | 2,687 | 3,934 | 4,786 | 5,961 | 7,521 |
| Tax payable | 42 | 59 | 216 | 300 | 370 | 488 |
| Other current liabilities | 3,291 | 3,933 | 4,762 | 5,177 | 7,129 | 8,034 |
| Contract liabilities | 212 | 208 | 173 | 368 | 478 | 618 |
| Accrued expenses | 443 | 592 | 924 | 1,284 | 1,581 | 2,088 |
| Non-current liabilities | 2,995 | 3,167 | 3,378 | 3,651 | 3,876 | 4,260 |
| Long-term borrowings | 2,407 | 2,577 | 2,679 | 2,679 | 2,679 | 2,679 |
| Bond payables | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income | 372 | 471 | 525 | 730 | 899 | 1,188 |
| Other non-current liabilities | 217 | 119 | 174 | 241 | 297 | 393 |
| Total liabilities | 9,420 | 10,656 | 13,402 | 20,707 | 23,054 | 29,360 |
| Share capital | 513 | 513 | 667 | 681 | 681 | 681 |
| Retained earnings | 6,179 | 7,594 | 10,024 | 14,361 | 21,603 | 31,759 |
| Other reserves | 6,492 | 6,510 | 6,459 | 6,728 | 6,972 | 7,309 |
| Total shareholders equity | 13,184 | 14,617 | 17,149 | 21,770 | 29,257 | 39,749 |
| Minority interest | 3 | 29 | 31 | 34 | 37 | 39 |
| Total equity and liabilities | 22,607 | 25,302 | 30,583 | 42,511 | 52,348 | 69,149 |
| CASH FLOW | 2023A | 2024A | 2025A | 2026E | 2027E | 2028E |
| YE 31 Dec (RMB mn) | ||||||
| Operating | ||||||
| Profit before taxation | 1,398 | 1,879 | 3,279 | 6,118 | 9,298 | 13,258 |
| Depreciation & amortization | 1,272 | 1,437 | 1,668 | 1,857 | 2,137 | 2,514 |
| Change in working capital | (364) | (846) | (1,611) | (5,248) | 1,738 | (6,180) |
| Others | 283 | 513 | 503 | (149) | 294 | (315) |
| Net cash from operations | 2,589 | 2,982 | 3,838 | 2,578 | 13,468 | 9,277 |
| Investing | ||||||
| Capital expenditure | (3,250) | (2,526) | (3,765) | (5,362) | (5,573) | (6,661) |
| Acquisition of subsidiaries/ investments | 0 | 0 | (904) | 0 | 0 | 0 |
| Net proceeds from disposal of short-term investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Others | (311) | 601 | 10 | 184 | 201 | 244 |
| Net cash from investing | (3,561) | (1,925) | (4,660) | (5,177) | (5,372) | (6,417) |
| Financing | ||||||
| Dividend paid | (589) | (543) | (846) | (1,772) | (1,993) | (2,959) |
| Net borrowings | 1,117 | 133 | 207 | 5,126 | (1,481) | 2,691 |
| Proceeds from share issues | 0 | 31 | 0 | 114 | 0 | 0 |
| Others | (617) | (10) | (11) | 14 | 14 | 14 |
| Net cash from financing | (89) | (389) | (650) | 3,483 | (3,460) | (254) |
| Net change in cash | ||||||
| Cash at the beginning of the year | 1,912 | 851 | 1,551 | 997 | 1,892 | 6,540 |
| Exchange difference | (0) | 32 | 12 | 12 | 12 | 12 |
| Cash at the end of the year | 851 | 1,551 | 997 | 1,892 | 6,540 | 9,158 |
| GROWTH | 2023A | 2024A | 2025A | 2026E | 2027E | 2028E |
| YE 31 Dec | ||||||
| Revenue | (3.3%) | 32.4% | 32.1% | 55.6% | 30.0% | 29.3% |
| Gross profit | (11.2%) | 40.3% | 50.6% | 78.0% | 35.9% | 36.7% |
| Operating profit | (14.3%) | 43.1% | 75.8% | 89.5% | 44.1% | 44.6% |
| Net profit | (14.8%) | 34.3% | 74.5% | 86.7% | 52.0% | 42.6% |
| PROFITABILITY | 2023A | 2024A | 2025A | 2026E | 2027E | 2028E |
| YE 31 Dec | ||||||
| Gross profit margin | 23.4% | 24.8% | 28.3% | 32.4% | 33.9% | 35.8% |
| Operating margin | 11.9% | 12.9% | 17.1% | 20.9% | 23.1% | 25.9% |
| Return on equity (ROE) | 11.0% | 13.5% | 20.6% | 31.4% | 36.4% | 38.4% |
| GEARING/LIQUIDITY/ACTIVITIES | 2023A | 2024A | 2025A | 2026E | 2027E | 2028E |
| YE 31 Dec | ||||||
| Current ratio (x) | 1.3 | 1.4 | 1.4 | 1.3 | 1.5 | 1.6 |
| VALUATION | 2023A | 2024A | 2025A | 2026E | 2027E | 2028E |
| YE 31 Dec | ||||||
| P/E | 104.6 | 77.7 | 57.9 | 31.0 | 20.4 | 14.3 |
| Source: Company data, CMBIGM estimates. Note: The calculation of net cash includes financial assets. | ||||||
Disclosures & Disclaimers
Analyst Certification
The research analyst who is primary responsible for the content of this research report, in whole or in part, certifies that with respect to the securities or issuer that the analyst covered in this report: (1) all of the views expressed accurately reflect his or her personal views about the subject securities or issuer; and (2) no part of his or her compensation was, is, or will be, directly or indirectly, related to the specific views expressed by that analyst in this report. Besides, the analyst confirms that neither the analyst nor his/her associates (as defined in the code of conduct issued by The Hong Kong Securities and Futures Commission) (1) have dealt in or traded in the stock(s) covered in this research report within 30 calendar days prior to the date of issue of this report; (2) wil deal in or trade in the stock(s) covered in this research report 3 business days after the date of issue of this report; (3) serve as an officer of any of the Hong Kong listed companies covered in this report; and (4) have any financial interests in the Hong Kong listed companies covered in this report.
CMBIGM Ratings
BUY
: Stock with potential return of over 15% over next 12 months
HOLD
: Stock with potential return of +15% to -10% over next 12 months
SELL
: Stock with potential loss of over 10% over next 12 months
NOT RATED
: Stock is not rated by CMBIGM
OUTPERFORM : Industry expected to outperform the relevant broad market benchmark over next 12 months
MARKET-PERFORM
: Industry expected to perform in-line with the relevant broad market benchmark over next 12 months
UNDERPERFORM : Industry expected to underperform the relevant broad market benchmark over next 12 months
CMB International Global Markets Limited
Address: 45/F, Champion Tower, 3 Garden Road, Hong Kong, Tel: (852) 3900 0888 Fax: (852) 3900 0800
CMB International Global Markets Limited (“CMBIGM”) is a wholly owned subsidiary of CMB International Capital Corporation Limited (a wholly owned subsidiary of China Merchants Bank)
Important Disclosures
There are risks involved in transacting in any securities. The information contained in this report may not be suitable for the purposes of all investors. CMBIGM does not provide individually tailored investment advice. This report has been prepared without regard to the individual investment objectives, financial position or special requirements. Past performance has no indication of future performance, and actual events may differ materially from that which is contained in the report. The value of, and returns from, any investments are uncertain and are not guaranteed and may fluctuate as a result of their dependence on the performance of underlying assets or other variable market factors. CMBIGM recommends that investors should independently evaluate particular investments and strategies, and encourages investors to consult with a professional financial advisor in order to make their own investment decisions.
This report or any information contained herein, has been prepared and distributed in Hong Kong by CMBIGM under its regulatory framework for the regulated activities licensed and regulated by the Securities and Futures Commission of Hong Kong. The report is solely for the purpose of supplying information to the clients of CMBIGM or its affiliate(s) to whom it is distributed. This report is not and should not be construed as an offer or solicitation to buy or sell any security or any interest in securities or enter into any transaction. Neither CMBIGM nor any of its affiliates, shareholders, agents, consultants, directors, officers or employees shall be liable for any loss, damage or expense whatsoever, whether direct or consequential, incurred in relying on the information contained in this report. Anyone making use of the information contained in this report does so entirely at their own risk.
The information and contents contained in this report are based on the analyses and interpretations of information believed to be publicly available and reliable. CMBIGM has exerted every effort in its capacity to ensure, but not to guarantee, their accuracy, completeness, timeliness or correctness. CMBIGM provides the information, advices and forecasts on an "AS IS" basis. The information and contents are subject to chan e without notice. CMBIGM may issue other publications having information and/ or conclusions different from this report. These publications reflect different assumption, point-of-view and analytica methods when compiling. CMBIGM may make investment decisions or take proprietary positions that are inconsistent with the recommendations or views in this report.
CMBIGM may have a position, make markets or act as principal or engage in transactions in securities of companies referred to in this report for itself and/or on behalf of its clients from time to time. Investors should assume that CMBIGM does or seeks to have investment banking or other business relationships with the companies in this report. As a result, recipients should be aware that CMBIGM may have a conflict of interest that could affect the objectivity of this report and CMBIGM will not assume any responsibility in respect thereof. This report is for the use of intended recipients only and this publication, may not be reproduced, reprinted, sold, redistributed, directly or indirectly, to any other person, published in whole or in part for any purpose without prior written consent of CMBIGM.
Additional information on recommended securities is available upon request. If there is any inconsistency between the Chinese and English versions of this Important Disclosure, the English version shall prevail.
For recipients of this document in the United Kingdom
This report has been provided only to persons (I)falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended from time to time)(“The Order”) or (II) are persons falling within Article 49(2) (a) to (d) (“High Net Worth Companies, Unincorporated Associations, etc.,) of the Order, and may not be provided to any other person without the prior written consent of CMBIGM.
For recipients of this document in the United States
CMBIGM is not a registered broker-dealer in the United States. As a result, CMBIGM is not subiect to US, rules regarding the preparation of research reports and the independence of research analysts. The research analyst who is primary responsible for the content of this research report is not registered or qualified as a research analyst with the Einancial Industry Regulatory Authority (“EINRA”). The analyst is not subiect to applicable restrictions under, EINRÀ, Rules intended to ensure that the analyst is not affected by potential conflicts of interest that could bear upon the reliability of the research report. This report is intended for distribution in the United States solely to "maior US institutional investors", as defined in Rule 15a-6 under the US. Securities Exchange Act of 1934, as amended, and may not be furnished to any other person in the United States. Each major US institutional investor that receives a copy of this report by its acceptance hereof represents and agrees that it shall not distribute or provide this report to any other person. Any U.S. recipient of this report wishing to effect any transaction to buy or sell securities based on the information provided in this report should do so only through a U.S.-registered broker-dealer.
For recipients of this document in Singapore
This report is distributed in Singapore by CMBI (Singapore) Pte. Limited (CMBISG) (Company Regn. No. 201731928D), an Exempt Financial Adviser as defined in the Financial Advisers Act (Cap. 110) of Singapore and regulated by the Monetary Authority of Singapore. CMBISG may distribute reports produced by its respective foreign entities, affiliates or other foreign research houses pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the report is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, as defined in the Securities and Futures Act (Cap. 289) of Singapore, CMBISG accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact CMBISG at +65 6350 4400 for matters arising from, or in connection with the report.
股票
板块
用户
资讯
评论 (0)